Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Maio

Showing results (31-40 of 250) with videos related to

Pageof 25
Sort By:
Immunotherapy|October 4, 2013
Epigenetics of melanoma: implications for immune-based therapiesElisabetta Fratta, Luca Sigalotti, Alessia Covre, et al.
Current Opinion in Oncology|January 10, 2013
Update on the role of ipilimumab in melanoma and first data on new combination therapiesMichele Maio, Anna M Di Giacomo, Caroline Robert, et al.
Cytokine & Growth Factor Reviews|July 25, 2017
Immunotherapy targeting immune check-point(s) in brain metastasesAnna Maria Di Giacomo, Monica Valente, Alessia Covre, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2014
"Cancer Bio-Immunotherapy in Siena": Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17-19, 2013Michele Maio, Hugues Jean Marie Nicolay, Ornella Cutaia, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Peptide-based vaccines for cancer therapyGiorgio Parmiani, Vincenzo Russo, Cristina Maccalli, et al.
Oncogene|October 7, 2003
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vesselsEster Fonsatti, Maresa Altomonte, Maria Rita Nicotra, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2009
Cancer testis antigens and melanoma stem cells: new promises for therapeutic interventionLuca Sigalotti, Alessia Covre, Hugues J M Nicolay, et al.
Cardiovascular Research|October 9, 2009
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumoursEster Fonsatti, Hugues J M Nicolay, Maresa Altomonte, et al.
Annals of the New York Academy of Sciences|October 12, 2012
Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyondRiccardo Danielli, Ester Fonsatti, Luana Calabrò, et al.
Vaccines|April 27, 2024
Improving Influenza Vaccination Coverage in Patients with Cancer: A Position Paper from a Multidisciplinary Expert GroupPaolo Bonanni, Michele Maio, Giordano D Beretta, et al.
Pageof 25

Showing results (31-40 of 250) with videos related to

Sort By:
Pageof 25
Immunotherapy|October 4, 2013
Epigenetics of melanoma: implications for immune-based therapiesElisabetta Fratta, Luca Sigalotti, Alessia Covre, et al.
Current Opinion in Oncology|January 10, 2013
Update on the role of ipilimumab in melanoma and first data on new combination therapiesMichele Maio, Anna M Di Giacomo, Caroline Robert, et al.
Cytokine & Growth Factor Reviews|July 25, 2017
Immunotherapy targeting immune check-point(s) in brain metastasesAnna Maria Di Giacomo, Monica Valente, Alessia Covre, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2014
"Cancer Bio-Immunotherapy in Siena": Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17-19, 2013Michele Maio, Hugues Jean Marie Nicolay, Ornella Cutaia, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Peptide-based vaccines for cancer therapyGiorgio Parmiani, Vincenzo Russo, Cristina Maccalli, et al.
Oncogene|October 7, 2003
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vesselsEster Fonsatti, Maresa Altomonte, Maria Rita Nicotra, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2009
Cancer testis antigens and melanoma stem cells: new promises for therapeutic interventionLuca Sigalotti, Alessia Covre, Hugues J M Nicolay, et al.
Cardiovascular Research|October 9, 2009
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumoursEster Fonsatti, Hugues J M Nicolay, Maresa Altomonte, et al.
Annals of the New York Academy of Sciences|October 12, 2012
Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyondRiccardo Danielli, Ester Fonsatti, Luana Calabrò, et al.
Vaccines|April 27, 2024
Improving Influenza Vaccination Coverage in Patients with Cancer: A Position Paper from a Multidisciplinary Expert GroupPaolo Bonanni, Michele Maio, Giordano D Beretta, et al.
Pageof 25